217 related articles for article (PubMed ID: 1743920)
1. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Press WR; Weinmann HJ
Invest Radiol; 1991 Nov; 26(11):969-74. PubMed ID: 1743920
[TBL] [Abstract][Full Text] [Related]
2. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
3. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat.
Van Hecke P; Marchal G; Bosmans H; Johannik K; Jiang Y; Vogler H; Van Ongeval C; Baert AL; Speck U
Magn Reson Imaging; 1991; 9(3):313-21. PubMed ID: 1881249
[TBL] [Abstract][Full Text] [Related]
4. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
Vexler VS; Clément O; Brasch RC
Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
[No Abstract] [Full Text] [Related]
5. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gadolinium-DTPA and macromolecular gadolinium-DTPA-polylysine for contrast-enhanced pulmonary time-of-flight magnetic resonance angiography.
Böck JC; Kaufmann F; Felix R
Invest Radiol; 1996 Oct; 31(10):652-7. PubMed ID: 8889654
[TBL] [Abstract][Full Text] [Related]
8. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR.
Schmiedl UP; Kenney J; Maravilla KR
AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491
[TBL] [Abstract][Full Text] [Related]
9. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G
Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents.
Laurent S; Burtea C; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2011; 6(4):229-35. PubMed ID: 21861283
[TBL] [Abstract][Full Text] [Related]
14. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging.
Schmiedl U; Brasch RC; Ogan MD; Moseley ME
Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977
[TBL] [Abstract][Full Text] [Related]
15. Facilitated magnetic resonance imaging diagnosis of pulmonary disease using a macromolecular blood-pool contrast agent, polylysine-(Gd-DTPA)40.
Brasch RC; Berthezene Y; Vexler VS; Moseley M; Clément O; Muehler A; Price D; Jerome H
Invest Radiol; 1991 Nov; 26 Suppl 1():S42-5; discussion S60-4. PubMed ID: 1808147
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
Wang X; Feng Y; Ke T; Schabel M; Lu ZR
Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
[TBL] [Abstract][Full Text] [Related]
17. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
18. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides.
Gibby WA; Billings J; Hall J; Ovitt TW
Invest Radiol; 1990 Feb; 25(2):164-72. PubMed ID: 1690184
[TBL] [Abstract][Full Text] [Related]
20. AUR Memorial Award 1991. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Induction and characterization of antibodies in animals.
Baxter AB; Melnikoff S; Stites DP; Brasch RC
Invest Radiol; 1991 Dec; 26(12):1035-40. PubMed ID: 1722486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
